Last reviewed: September 22, 2025 What this article covers: why the psychedelic facilitator–client relationship is often more important than the medicine itself, what training and qualities matter most, how cultural fit shapes outcomes, and how seekers can evaluate...
Brian, a JourneyŌM guide reflects on presence, capacity, and the steady work of being human. It’s Supposed To Hurt… …at least some of the time. I’ve allowed this to partially sink in, against my will, kicking and screaming, over the past 10 years as my personal work...
In recent years, ketamine therapy has emerged as one of the most promising tools in the psychedelic-assisted therapy landscape. Originally developed as an anesthetic, ketamine is now showing remarkable potential for conditions like depression, PTSD, and...
It starts innocently enough. You’re prepping for a solo psilocybin experience. You dim the lights, queue your playlist, and open an app that promises structured prompts, real-time check-ins, and therapeutic journaling support. No human needed. It’s like having a guide...
When Nico sat across from his psychiatrist after trying yet another antidepressant that didn’t work, he wasn’t angry—he was numb. Thirty years of depression had taught him to live in grayscale. Therapy, medications, even TMS had provided temporary relief, but...
A Breakthrough in Rapid-Acting Psychedelics A new wave of clinical research is reshaping how we think about treating depression. Recent phase 2 trial results for BPL-003, a 5-MeO-DMT nasal spray, and mebufotenin benzoate spray point to a powerful possibility:...
